Research note — 8 August 2026. Educational only; not investment advice. IPO prices, subscription, and grey-market indications can change intraday. Verify the final RHP, exchange bid file, and your broker’s live screen before acting.

Seven IPOs, seven different risk profiles

The screen groups together businesses that should not be compared on one number. Technocraft and LEAP are live mainboard offers; Dhoot, Molbio and Milky Mist are forthcoming mainboard offers; LAPL and Optimystix are SME offers. A high subscription multiple measures applications for a scarce allocation; it does not establish business quality or fair value. An unregulated GMP is even weaker evidence: it is not a traded, enforceable price and can reverse abruptly.

The right decision is therefore a sequence: business durability → earnings quality and cash conversion → balance sheet and use of proceeds → price paid → issue mechanics/liquidity. The answer can differ for a listing-trade application and a multi-year holding.

Live snapshot from the supplied screen

OfferCloseScreen subscriptionWhat that does—and does not—say
Technocraft Ventures11 Aug2.59xPositive early demand, but not enough time to infer final QIB/retail mix.
LEAP India11 Aug0.26xEarly weak aggregate demand; assess category data near close, not one early print.
Dhoot Transmission12 AugPre-applyMainboard auto-electrical component scale story; price must be tested against normalised returns.
Molbio Diagnostics12 AugPre-applyHigher-quality differentiated diagnostic-platform story, but also a higher-expectation valuation question.
Milky Mist Dairy Food13 AugPre-applyConsumer-brand/food growth story where raw-milk cost and working-capital discipline matter.
LAPL Automotive (SME)10 Aug29.28xVery strong demand signal; it does not remove SME liquidity, allocation, or post-listing volatility risk.
Optimystix Entertainment (SME)11 Aug0.63xSoft initial demand; results are project-driven and need careful revenue-recognition scrutiny.

Subscription figures above are transcribed from the supplied screen; date/time and category break-up were not visible. Treat them as a snapshot, not a final-exchange figure.

How to read the ranking in this note

  • Business-quality watchlist: Dhoot and Molbio stand out for scale/differentiation, subject to valuation and RHP risk review.
  • Execution and valuation watchlist: Milky Mist, Technocraft and LEAP have credible narratives, but the investment case turns on their specific capital intensity, cash conversion and price.
  • High-risk SME bucket: LAPL and Optimystix require a separate position-size and liquidity rule; do not use mainboard allocation habits here.

1. Technocraft Ventures — infrastructure execution is the core underwriting question

Offer context. The current offer is reported at INR 200–212 per share, with a 70-share lot and an approximately INR 251.9 crore issue comprising a roughly INR 201.5 crore fresh issue and INR 50.4 crore OFS. At the cap price, reported FY26 revenue/PAT are approximately INR 347 crore/INR 43.3 crore, implying a trailing PAT margin near 12.5%. Those terms should be reconciled to the final RHP before application.

What works. A water/infrastructure EPC business can benefit from a long public-capex runway. Growth from approximately INR 227 crore revenue and INR 19 crore PAT in FY24 to the reported FY26 figures suggests operating leverage if execution, receivables and working capital are controlled. The fresh-issue component matters more than the OFS because it can strengthen capacity and balance-sheet flexibility.

What can break. EPC revenue is not equivalent to recurring revenue. Order-book conversion can be delayed by approvals, site access, customer decisions and contract variations. Low-quality growth normally appears first in receivable days, unbilled revenue, retention money, cost overruns or a widening gap between PAT and operating cash flow. Public-sector concentration also raises payment-cycle risk. Ask: (1) what share of the order book is from the top five customers, (2) what is the unexecuted order book relative to FY26 revenue, (3) has gross margin held across projects, and (4) has cash from operations tracked PAT over three years?

Valuation lens. Do not value it solely on a one-year growth burst. Compare cap-price P/E with durable, cash-backed earnings; then haircut the multiple if receivables, contingent liabilities or customer concentration are elevated. A short-term subscription result should not substitute for this work.

2. LEAP India — a returnable-packaging platform with a large OFS

Offer context. The reported INR 151–159 issue has a 94-share retail lot. It is a large approximately INR 2,480 crore offer: about INR 480 crore fresh and INR 2,000 crore OFS, plus a reported employee reservation. The reported use of fresh proceeds includes debt repayment and working capital. That mix is important: much of the transaction monetises existing holders, while only the fresh portion enters the company.

The business case. LEAP rents and manages reusable pallets, crates and other returnable assets for supply chains. The attractive version of this model is asset density: more customers, lanes and use-cases increase utilisation and generate repeat rental/service revenue. FY26 reported revenue/PAT of roughly INR 747.5 crore/INR 63 crore imply an 8.4% PAT margin after growth from about INR 372 crore/INR 37 crore in FY24.

Where judgement is required. This is not a conventional low-capex software-like logistics story. Asset purchases, loss/damage, repair, reverse-logistics and debt funding are central. The investor should map: asset base and depreciation; utilisation by product; replacement and loss rates; debt/EBITDA; customer concentration; contract tenure/price-escalation; and whether operating cash flow supports rental-asset additions. The reported upper-price post-issue market value near INR 7,005 crore would be over 100x reported FY26 PAT if those figures are comparable—an expectation-heavy starting point. That may be justified only if utilisation, returns and cash generation can compound materially.

Decision implication. Early subscription of 0.26x is not a verdict, but it highlights that the large supply and valuation debate need attention. For a long-term investor, the key question is whether the returnable-asset network earns high incremental returns after all asset and loss costs—not whether the logistics theme sounds compelling.

3. Dhoot Transmission — strongest disclosed scale, but returns have normalised

What it does. Dhoot supplies integrated wiring harnesses, electronics, EV systems and automotive switches. Its disclosed FY26 revenue was INR 4,524.96 crore, with 2W at INR 2,962.70 crore and 3W at INR 581.78 crore; EV revenue was 24.17% of total. It had 22 manufacturing plants and 74.26% capacity utilisation.

Growth versus quality. FY26 revenue grew 31.35% and PAT reached INR 396.84 crore. Yet EBITDA margin fell to 15.71% from 17.15% in FY25 and PAT margin to 8.70% from 10.19%. RoCE fell from 29.66% to 19.14%, while stated ROE fell from 35.60% to 16.30%. The offer documents explain that a late-March capital infusion distorted reported capital; adjusted metrics excluding that undeployed cash are higher. Still, the direction of operating margins deserves more weight than the adjustment.

Price and relative frame. The INR 829–871 band equals 33.98x–35.70x FY26 EPS. The RHP’s selected peer composite P/E is 55.31x, with Motherson Sumi Wiring at 43.24x and Sona BLW at 74.64x (all based on 31 July 2026 prices). A discount to peers is not automatically cheap: peers can have different customer concentration, product complexity, balance sheets and return profiles. The fresh issue is reported near INR 1,400 crore and OFS near INR 1,666.9 crore; make a line-by-line use-of-funds check, particularly debt reduction and capacity expansion.

What would change the conclusion. Confirm top-customer exposure, programme/platform duration, raw-material pass-through, EV share economics, utilisation ramp and free cash flow after capex. A valuable result would be evidence that margin pressure is temporary while EV content per vehicle and capacity utilisation keep rising. A negative result would be revenue growth with continuing margin/ROCE dilution.

4. Molbio Diagnostics — differentiated technology, but validate concentration and tender economics

What makes it different. Molbio’s Truenat platform brings real-time PCR molecular testing closer to the point of care. The company says it has touched 40+ million lives across 85+ countries and highlights WHO/health-system adoption in TB-related testing. Its wholly owned Bigtec Labs supports R&D and platform development. This is a more defensible proposition than a generic diagnostics distributor if the installed base drives recurring assay/consumable revenue.

Financial/offer lens. Reported FY26 revenue/PAT are about INR 1,455.2 crore/INR 164.1 crore—an 11.3% PAT margin—following approximately INR 1,028 crore/INR 138.6 crore in FY25. The reported INR 768–807 band, 18-share lot and approximately INR 939.7 crore offer include only INR 200 crore fresh issue and roughly INR 739.7 crore OFS. This raises a simple question: how much future growth is already reflected in the offer price when most proceeds monetise existing shareholders?

Key diligence items. Separate instrument sales from consumables/services; assess installed-base utilisation; map country and government-tender concentration; identify regulatory approvals and renewal risk; test pricing/competition versus central-lab and other point-of-care platforms; and understand foreign-exchange, inventory and receivables exposure. Disease programmes can create step-change demand but can also be policy/tender dependent. The strongest long-term thesis is repeat consumables revenue attached to a durable installed base, not a one-off pandemic/outbreak demand spike.

5. Milky Mist Dairy Food — a premium-value-added dairy bet, not a commodity-milk bet

The business case. Milky Mist spans paneer, cheese, curd, butter, ghee, yogurt, UHT products, ice cream and adjacent convenience foods. Its broad value-added portfolio can support better mix than liquid milk, while brand, cold chain and procurement are real operating assets. The company also describes a Tamil Nadu farmer procurement network and renewable-energy capacity.

Offer and numbers. Reported terms are INR 133–140, a 107-share lot and a roughly INR 1,553 crore offer: about INR 1,428 crore fresh and INR 125 crore OFS. Reported FY26 revenue/PAT are INR 3,145 crore/INR 127 crore, versus INR 2,355 crore/INR 46 crore in FY25. That is a large profit inflection, but the resulting PAT margin remains only about 4.0%, so small procurement, pricing or wastage changes can materially affect earnings.

What matters more than the brand. Track milk procurement costs, gross-margin stability, refrigerated distribution economics, receivable/inventory days, returns/expiry losses, geographic concentration and whether new categories earn their cost of capital. The pre-IPO transaction reportedly valued the company around INR 9,300 crore at a share price close to INR 140; against reported INR 127 crore PAT, that is roughly a low-70s P/E starting point. That is an inference, not the final post-issue valuation; verify share count and RHP EPS. Capacity expansion and debt repayment can help, but only if incremental capacity is filled without sacrificing margins.

6. LAPL Automotive (SME) — demand is exceptional; structural SME risks remain

Mechanics. The offer is a fixed-price BSE SME issue at INR 78, with 1,600 shares per lot and minimum investment of INR 124,800. Reported issue size is INR 28.08 crore. The screen shows 29.28x aggregate subscription before close.

Interpretation. Scarcity can magnify SME subscription and listing moves. It can also make allocation tiny, post-listing spreads wide and exits difficult. Do not extrapolate a 29x subscription print into an intrinsic-value conclusion. Before applying, read the final prospectus for the latest revenue/PAT, customer concentration, related-party transactions, debtor ageing, inventory and use of funds. Fixed-price issues require even more independent valuation work because there is no book-built price-discovery signal.

Practical rule. Treat this only as a high-volatility sleeve, use money you can leave locked up, and predefine an exit/holding framework. A high application amount is not diversification.

7. Optimystix Entertainment (SME) — turnaround numbers require revenue-recognition discipline

What it does. Optimystix produces television programmes, digital content, films, and content-exploitation/licensing; it also provides consulting/production services. Its own restated accounts state that commissioned work is recognised by contract milestones, whereas self-produced/traded content is recognised on delivery/sale terms. That makes contract completion, delivery and content-rights assumptions especially material.

Financial read. Restated consolidated FY25 revenue from operations was INR 124.39 crore, versus INR 54.76 crore in FY24 and INR 31.10 crore in FY23. Restated FY25 PAT was INR 17.22 crore versus INR 6.65 crore in FY24 and a loss in FY23; reported PAT margin rose to 13.84%. This is an impressive recovery—but two years of large swings mean it is not yet proof of a smooth annuity model.

What to test. Identify the programmes/customers behind FY25, whether revenue is repeatable, unbilled receivables and contract assets, ownership/monetisation of intellectual property, content impairment policy, related-party flows, and cash collections relative to reported profit. The screen’s 0.63x subscription is only a current-demand data point. The stronger concern is whether earnings are durable after project timing and accounting judgements normalise.

Portfolio-level conclusion: separate quality from trade setup

  1. For business quality: start with Dhoot and Molbio. Dhoot has disclosed scale and a direct peer framework; Molbio has platform differentiation and potential recurring consumables. Neither is a blank cheque: Dhoot’s margin/return trend and Molbio’s tender/regulatory/valuation exposure are decisive.
  2. For a long-duration execution thesis: Milky Mist and LEAP need valuation-sensitive underwriting. Milky Mist’s mix-led consumer franchise must show stable margins and cash conversion. LEAP must prove asset utilisation and returns after capital intensity, not merely revenue growth.
  3. For an infrastructure-cycle thesis: Technocraft hinges on cash-backed project execution, receivables and order-book quality.
  4. For SME participation: LAPL and Optimystix should be analysed as special situations with limited liquidity, not as smaller versions of mainboard IPOs.

Final application checklist

  • Read the final RHP’s risk factors, objects of the issue, capitalisation, related-party transactions, litigations and peer comparison.
  • Use FY26 EPS and post-issue shares for P/E; do not divide issue size by PAT or compare unrelated sector multiples.
  • Reconcile PAT with operating cash flow, capex, debt and working-capital movement for all capital-intensive businesses.
  • Inspect QIB/NII/retail subscription separately on the final day; aggregate demand hides the most informative category mix.
  • Ignore GMP as a valuation input. If used at all, label it an unregulated sentiment indicator with a timestamp.
  • Size each application for the risk of poor allocation, listing volatility, and—in SME offers—illiquidity.

Primary and supporting sources